Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Malcolm D Mason

Showing results (31-40 of 146) with videos related to

Pageof 15
Sort By:
Molecular and Cellular Biochemistry|December 15, 2012
Matriptase-2 inhibits HECV motility and tubule formation in vitro and tumour angiogenesis in vivoSiobhan L Webb, Andrew J Sanders, Malcolm D Mason, et al.
Frontiers in Bioscience (Landmark Edition)|January 4, 2011
Type II transmembrane serine protease (TTSP) deregulation in cancerSiobhan L Webb, Andrew J Sanders, Malcolm D Mason, et al.
BJU International|September 29, 2011
The role of surgery in high-risk localised prostate cancerVincent J Gnanapragasam, Malcolm D Mason, Greg L Shaw, et al.
Anticancer Research|March 8, 2011
HAVcR-1 reduces the integrity of human endothelial tight junctionsTracey A Martin, Gregory M Harrison, Malcolm D Mason, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 17, 2011
Cancer exosomes express CD39 and CD73, which suppress T cells through adenosine productionAled Clayton, Saly Al-Taei, Jason Webber, et al.
Journal of Experimental Therapeutics & Oncology|August 26, 2010
The differential expression of hCNT1 and hENT1 i n breast cancer and the possible impact on breast cancer therapyJane Lane, Tracey A Martin, Christopher McGuigan, et al.
International Journal of Oncology|June 28, 2014
Tumour angiogenesis and repulsive guidance molecule b: a role in HGF- and BMP-7-mediated angiogenesisAndrew J Sanders, Lin Ye, Jin Li, et al.
European Journal of Immunology|March 21, 2003
Antigen-presenting cell exosomes are protected from complement-mediated lysis by expression of CD55 and CD59Aled Clayton, Claire L Harris, Jacquelyn Court, et al.
Cancer Research|August 3, 2005
Recovery of CD8+ T-cell function during systemic chemotherapy in advanced ovarian cancerSharon Coleman, Aled Clayton, Malcolm D Mason, et al.
Anticancer Research|December 26, 2012
Expression profile of receptor activator of nuclear-κB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancerSioned Owen, Lin Ye, Andrew J Sanders, et al.
Pageof 15

Showing results (31-40 of 146) with videos related to

Sort By:
Pageof 15
Molecular and Cellular Biochemistry|December 15, 2012
Matriptase-2 inhibits HECV motility and tubule formation in vitro and tumour angiogenesis in vivoSiobhan L Webb, Andrew J Sanders, Malcolm D Mason, et al.
Frontiers in Bioscience (Landmark Edition)|January 4, 2011
Type II transmembrane serine protease (TTSP) deregulation in cancerSiobhan L Webb, Andrew J Sanders, Malcolm D Mason, et al.
BJU International|September 29, 2011
The role of surgery in high-risk localised prostate cancerVincent J Gnanapragasam, Malcolm D Mason, Greg L Shaw, et al.
Anticancer Research|March 8, 2011
HAVcR-1 reduces the integrity of human endothelial tight junctionsTracey A Martin, Gregory M Harrison, Malcolm D Mason, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 17, 2011
Cancer exosomes express CD39 and CD73, which suppress T cells through adenosine productionAled Clayton, Saly Al-Taei, Jason Webber, et al.
Journal of Experimental Therapeutics & Oncology|August 26, 2010
The differential expression of hCNT1 and hENT1 i n breast cancer and the possible impact on breast cancer therapyJane Lane, Tracey A Martin, Christopher McGuigan, et al.
International Journal of Oncology|June 28, 2014
Tumour angiogenesis and repulsive guidance molecule b: a role in HGF- and BMP-7-mediated angiogenesisAndrew J Sanders, Lin Ye, Jin Li, et al.
European Journal of Immunology|March 21, 2003
Antigen-presenting cell exosomes are protected from complement-mediated lysis by expression of CD55 and CD59Aled Clayton, Claire L Harris, Jacquelyn Court, et al.
Cancer Research|August 3, 2005
Recovery of CD8+ T-cell function during systemic chemotherapy in advanced ovarian cancerSharon Coleman, Aled Clayton, Malcolm D Mason, et al.
Anticancer Research|December 26, 2012
Expression profile of receptor activator of nuclear-κB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancerSioned Owen, Lin Ye, Andrew J Sanders, et al.
Pageof 15